Campbell & Co Investment Adviser’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,530
| Closed | -$282K | – | 1174 |
|
|
2025
Q1 | $282K | Buy |
+15,530
| New | +$282K | 0.02% | 863 |
|
|
2024
Q2 | – | Sell |
-19,166
| Closed | -$804K | – | 1081 |
|
|
2024
Q1 | $804K | Buy |
+19,166
| New | +$804K | 0.07% | 489 |
|
|
2022
Q3 | – | Sell |
-8,052
| Closed | -$217K | – | 732 |
|
|
2022
Q2 | $217K | Sell |
8,052
-640
| -7% | -$17.2K | 0.06% | 579 |
|
|
2022
Q1 | $296K | Buy |
8,692
+1,092
| +14% | +$37.2K | 0.08% | 479 |
|
|
2021
Q4 | $294K | Sell |
7,600
-3,500
| -32% | -$135K | 0.1% | 368 |
|
|
2021
Q3 | $599K | Buy |
11,100
+3,100
| +39% | +$167K | 0.2% | 163 |
|
|
2021
Q2 | $268K | Buy |
+8,000
| New | +$268K | 0.11% | 354 |
|